Study of Milnacipran for the Treatment of Fibromyalgia
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Antidepressants of all varieties represent a common form of therapy for many chronic states
including fibromyalgia. The majority of antidepressants increase the levels of serotonin or
norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and
serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.